Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.

Abstract

The pharmacological treatment of pituitary tumours is based on the use of stable analogues of somatostatin and dopamine. The analogues bind to somatostatin receptor types 2 and 5 (SST2 and SST5) and dopamine receptor type 2 (DRD2), respectively, and generate signal transduction cascades in cancerous pituitary cells that culminate in the inhibition of hormone secretion, cell growth and invasion. Drug resistance occurs in a subset of patients and can involve different steps at different stages, such as following receptor activation by the agonist or during the final biological responses. Although the expression of somatostatin and dopamine receptors in cancer cells is a prerequisite for these drugs to reach a biological effect, their presence does not guarantee the success of the therapy. Successful therapy also requires the proper functioning of the machinery of signal transduction and the finely tuned regulation of receptor desensitization, internalization and intracellular trafficking. The present Review provides an updated overview of the molecular factors underlying the pharmacological resistance of pituitary tumours. The Review discusses the experimental evidence that supports a role for receptors and intracellular proteins in the function of SSTs and DRD2 and their clinical importance.

• Authors: Erika Peverelli, Donatella Treppiedi, Federica Mangili, Rosa Catalano, Anna Spada, Giovanna Mantovani
• Journal: Nature reviews. Endocrinology (Nat Rev Endocrinol) Vol. 17 Issue 9 Pg. 560-571 (09 2021) ISSN: 1759-5037 [Electronic] England
• PMID: 34194011 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2021. Springer Nature Limited.

Chemical References

• Intracellular Signaling Peptides and Proteins

Topics

• Adenoma (drug therapy, pathology)
• Animals
• Cell Membrane (drug effects, physiology)
• Drug Resistance, Neoplasm (physiology)
• Humans
• Intracellular Signaling Peptides and Proteins (physiology)
• Pituitary Neoplasms (drug therapy, pathology)
• Signal Transduction (drug effects)